Defective protein degradation in genetic disorders
Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are res...
Gespeichert in:
Veröffentlicht in: | Biochimica et biophysica acta. Molecular basis of disease 2022-05, Vol.1868 (5), p.166366-166366, Article 166366 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 166366 |
---|---|
container_issue | 5 |
container_start_page | 166366 |
container_title | Biochimica et biophysica acta. Molecular basis of disease |
container_volume | 1868 |
creator | Castel, Pau |
description | Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are responsible for the disease phenotype. Among the different cellular pathways that regulate active proteolysis, the Cullin RING E3 ligases represent an important group of sophisticated enzymatic complexes that mediate substrate ubiquitination through the interaction with specific adaptors. However, pathogenic variants in these adaptors affect the physiological ubiquitination of their substrates. This review discusses our current understanding of this emerging field.
•Many genetic disorders are caused by mutations in the ubiquitin-proteasome system.•Cullin RING E3 ubiquitin ligases (CRL) require adaptor proteins and substrate receptors.•CRL3 requires BTB proteins as substrate receptors.•Germline variants in genes encoding substrate receptors lead to different genetic conditions. |
doi_str_mv | 10.1016/j.bbadis.2022.166366 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8977116</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0925443922000291</els_id><sourcerecordid>2629057293</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-bf4fdd8c8cec31020cc0d364368a8a9b186000b584b9167e6fa318617100bd263</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMotlbfQGSWbqbmMpNJNoLUKxTcKLgLmeRMTZlOajIt-PamtFbdmM0h5_L_53wInRM8Jpjwq_m4rrV1cUwxpWPCOeP8AA2JqGROOX47REMsaZkXBZMDdBLjHKfHK3yMBqwkpcBEDhG9hQZM79aQLYPvwXWZhVnQVvfOd1n6zqCD3pksWflgIcRTdNToNsLZLo7Q6_3dy-Qxnz4_PE1uprkpOOvzuikaa4URBgwjmGJjsGW8YFxooWVNBE_71KUoakl4BbzRLOVIRVLWUs5G6Hqru1zVC7AGuj7oVi2DW-jwqbx26m-lc-9q5tdKyKoiZCNwuRMI_mMFsVcLFw20re7Ar6KinEpcVlSy1FpsW03wMQZo9jYEqw1uNVdb3GqDW21xp7GL3yvuh775_twACdTaQVDROOgMWBcSdmW9-9_hCy0Xkt8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2629057293</pqid></control><display><type>article</type><title>Defective protein degradation in genetic disorders</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Castel, Pau</creator><creatorcontrib>Castel, Pau</creatorcontrib><description>Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are responsible for the disease phenotype. Among the different cellular pathways that regulate active proteolysis, the Cullin RING E3 ligases represent an important group of sophisticated enzymatic complexes that mediate substrate ubiquitination through the interaction with specific adaptors. However, pathogenic variants in these adaptors affect the physiological ubiquitination of their substrates. This review discusses our current understanding of this emerging field.
•Many genetic disorders are caused by mutations in the ubiquitin-proteasome system.•Cullin RING E3 ubiquitin ligases (CRL) require adaptor proteins and substrate receptors.•CRL3 requires BTB proteins as substrate receptors.•Germline variants in genes encoding substrate receptors lead to different genetic conditions.</description><identifier>ISSN: 0925-4439</identifier><identifier>ISSN: 1879-260X</identifier><identifier>EISSN: 1879-260X</identifier><identifier>DOI: 10.1016/j.bbadis.2022.166366</identifier><identifier>PMID: 35158019</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>BTB proteins ; Congenital disorders ; CRL3 ; Cullin 3 ; Cullin Proteins - genetics ; Cullin Proteins - metabolism ; LZTR1 ; Proteolysis ; Ubiquitin ; Ubiquitination</subject><ispartof>Biochimica et biophysica acta. Molecular basis of disease, 2022-05, Vol.1868 (5), p.166366-166366, Article 166366</ispartof><rights>2022 Elsevier B.V.</rights><rights>Copyright © 2022 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-bf4fdd8c8cec31020cc0d364368a8a9b186000b584b9167e6fa318617100bd263</citedby><cites>FETCH-LOGICAL-c463t-bf4fdd8c8cec31020cc0d364368a8a9b186000b584b9167e6fa318617100bd263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbadis.2022.166366$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35158019$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castel, Pau</creatorcontrib><title>Defective protein degradation in genetic disorders</title><title>Biochimica et biophysica acta. Molecular basis of disease</title><addtitle>Biochim Biophys Acta Mol Basis Dis</addtitle><description>Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are responsible for the disease phenotype. Among the different cellular pathways that regulate active proteolysis, the Cullin RING E3 ligases represent an important group of sophisticated enzymatic complexes that mediate substrate ubiquitination through the interaction with specific adaptors. However, pathogenic variants in these adaptors affect the physiological ubiquitination of their substrates. This review discusses our current understanding of this emerging field.
•Many genetic disorders are caused by mutations in the ubiquitin-proteasome system.•Cullin RING E3 ubiquitin ligases (CRL) require adaptor proteins and substrate receptors.•CRL3 requires BTB proteins as substrate receptors.•Germline variants in genes encoding substrate receptors lead to different genetic conditions.</description><subject>BTB proteins</subject><subject>Congenital disorders</subject><subject>CRL3</subject><subject>Cullin 3</subject><subject>Cullin Proteins - genetics</subject><subject>Cullin Proteins - metabolism</subject><subject>LZTR1</subject><subject>Proteolysis</subject><subject>Ubiquitin</subject><subject>Ubiquitination</subject><issn>0925-4439</issn><issn>1879-260X</issn><issn>1879-260X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKAzEUhoMotlbfQGSWbqbmMpNJNoLUKxTcKLgLmeRMTZlOajIt-PamtFbdmM0h5_L_53wInRM8Jpjwq_m4rrV1cUwxpWPCOeP8AA2JqGROOX47REMsaZkXBZMDdBLjHKfHK3yMBqwkpcBEDhG9hQZM79aQLYPvwXWZhVnQVvfOd1n6zqCD3pksWflgIcRTdNToNsLZLo7Q6_3dy-Qxnz4_PE1uprkpOOvzuikaa4URBgwjmGJjsGW8YFxooWVNBE_71KUoakl4BbzRLOVIRVLWUs5G6Hqru1zVC7AGuj7oVi2DW-jwqbx26m-lc-9q5tdKyKoiZCNwuRMI_mMFsVcLFw20re7Ar6KinEpcVlSy1FpsW03wMQZo9jYEqw1uNVdb3GqDW21xp7GL3yvuh775_twACdTaQVDROOgMWBcSdmW9-9_hCy0Xkt8</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>Castel, Pau</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220501</creationdate><title>Defective protein degradation in genetic disorders</title><author>Castel, Pau</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-bf4fdd8c8cec31020cc0d364368a8a9b186000b584b9167e6fa318617100bd263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>BTB proteins</topic><topic>Congenital disorders</topic><topic>CRL3</topic><topic>Cullin 3</topic><topic>Cullin Proteins - genetics</topic><topic>Cullin Proteins - metabolism</topic><topic>LZTR1</topic><topic>Proteolysis</topic><topic>Ubiquitin</topic><topic>Ubiquitination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castel, Pau</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biochimica et biophysica acta. Molecular basis of disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castel, Pau</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defective protein degradation in genetic disorders</atitle><jtitle>Biochimica et biophysica acta. Molecular basis of disease</jtitle><addtitle>Biochim Biophys Acta Mol Basis Dis</addtitle><date>2022-05-01</date><risdate>2022</risdate><volume>1868</volume><issue>5</issue><spage>166366</spage><epage>166366</epage><pages>166366-166366</pages><artnum>166366</artnum><issn>0925-4439</issn><issn>1879-260X</issn><eissn>1879-260X</eissn><abstract>Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are responsible for the disease phenotype. Among the different cellular pathways that regulate active proteolysis, the Cullin RING E3 ligases represent an important group of sophisticated enzymatic complexes that mediate substrate ubiquitination through the interaction with specific adaptors. However, pathogenic variants in these adaptors affect the physiological ubiquitination of their substrates. This review discusses our current understanding of this emerging field.
•Many genetic disorders are caused by mutations in the ubiquitin-proteasome system.•Cullin RING E3 ubiquitin ligases (CRL) require adaptor proteins and substrate receptors.•CRL3 requires BTB proteins as substrate receptors.•Germline variants in genes encoding substrate receptors lead to different genetic conditions.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35158019</pmid><doi>10.1016/j.bbadis.2022.166366</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0925-4439 |
ispartof | Biochimica et biophysica acta. Molecular basis of disease, 2022-05, Vol.1868 (5), p.166366-166366, Article 166366 |
issn | 0925-4439 1879-260X 1879-260X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8977116 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals |
subjects | BTB proteins Congenital disorders CRL3 Cullin 3 Cullin Proteins - genetics Cullin Proteins - metabolism LZTR1 Proteolysis Ubiquitin Ubiquitination |
title | Defective protein degradation in genetic disorders |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T14%3A20%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defective%20protein%20degradation%20in%20genetic%20disorders&rft.jtitle=Biochimica%20et%20biophysica%20acta.%20Molecular%20basis%20of%20disease&rft.au=Castel,%20Pau&rft.date=2022-05-01&rft.volume=1868&rft.issue=5&rft.spage=166366&rft.epage=166366&rft.pages=166366-166366&rft.artnum=166366&rft.issn=0925-4439&rft.eissn=1879-260X&rft_id=info:doi/10.1016/j.bbadis.2022.166366&rft_dat=%3Cproquest_pubme%3E2629057293%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2629057293&rft_id=info:pmid/35158019&rft_els_id=S0925443922000291&rfr_iscdi=true |